Related Experiment Video
Updated: May 1, 2026

Assessment of Kidney Function in Mouse Models of Glomerular Disease
Published on: June 30, 2018
Novel biomarkers in glomerular disease
Yasar Caliskan1, Krzysztof Kiryluk1
1Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey and Division of Nephrology, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY; and Division of Nephrology, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY.
Novel biomarkers offer hope for predicting the course of glomerular diseases, moving beyond invasive kidney biopsies for diagnosis and prognosis. This research highlights promising advancements for conditions like IgA nephropathy and focal segmental glomerulosclerosis.
Area of Science:
- Nephrology
- Biomarker Discovery
- Genetics and Molecular Biology
Background:
- Glomerular diseases significantly contribute to end-stage kidney disease globally.
- Current diagnostic methods, primarily kidney biopsy, are invasive and have limitations in predicting disease progression and treatment response.
- Clinical outcomes for glomerular diseases are highly variable, ranging from spontaneous remission to rapid progression.
Purpose of the Study:
- To review emerging novel biomarkers for major glomerular diseases.
- To explore the potential of these biomarkers for noninvasive diagnosis and improved prognostication.
- To focus on key conditions including immunoglobulin A nephropathy, membranous nephropathy, focal segmental glomerulosclerosis, and membranoproliferative glomerulonephritis.
Main Methods:
- Literature review of recent advances in genetics and molecular biology related to glomerular diseases.
- Identification and analysis of promising novel biomarkers.
- Synthesis of current knowledge on biomarker development for specific glomerular diseases.
Main Results:
- Advances in genetics and molecular biology are elucidating novel pathogenic mechanisms.
- Novel biomarkers are emerging with the potential for noninvasive diagnosis.
- These biomarkers offer improved prospects for predicting clinical course and treatment response.
Conclusions:
- Emerging biomarkers hold significant promise for transforming the diagnosis and management of glomerular diseases.
- Noninvasive biomarkers could reduce reliance on kidney biopsies, improving patient safety and prognostication.
- Continued research in this area is crucial for developing targeted therapies and personalized medicine approaches for kidney disease.
Related Concept Videos
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Serum Studies: Renal Function Tests
Diabetic Nephropathy

